A Novel Combination Oral Agent to Treat Acne Vulgaris
-
- STATUS
- Not Recruiting
-
- participants needed
- 60
-
- sponsor
- Nexgen Dermatologics, Inc.
Updated on 6 November 2024
Accepts healthy volunteers
Summary
The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females
Details
| Condition | ACNE VULGARIS |
|---|---|
| Age | 13years - 60years |
| Treatment | Doxycycline, Doxycycline and S-equol |
| Clinical Study Identifier | NCT01301586 |
| Sponsor | Nexgen Dermatologics, Inc. |
| Last Modified on | 6 November 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.